Bilal Younes, Dorothee Mielke, Charlotte Flüh, Veit Rohde, Tammam Abboud
{"title":"化脓性脊柱炎器械治疗后因构造失败进行翻修手术的危险因素。","authors":"Bilal Younes, Dorothee Mielke, Charlotte Flüh, Veit Rohde, Tammam Abboud","doi":"10.1016/j.bas.2026.106283","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Construct failure following instrumented treatment for pyogenic spondylodiscitis remains a significant clinical challenge and is often associated with persistent pain or neurological deterioration requiring revision surgery. This study aimed to identify risk factors for construct failure requiring revision surgery after instrumented treatment of pyogenic spondylodiscitis.</p><p><strong>Methods: </strong>This retrospective single-center cohort study included 355 patients who underwent dorsal spinal instrumentation with or without anterior reconstruction for pyogenic spondylodiscitis at the University Medical Center Göttingen between 2013 and 2022. Construct failure requiring revision surgery was defined as the primary endpoint. Time-to-event analyses were performed using Kaplan-Meier survival estimates and Cox proportional hazards regression models. Baseline predictors included age, Charlson Comorbidity Index (CCI), preoperative C-reactive protein (CRP), and osteoporosis. An extended model additionally incorporated postoperative relapse infection and wound infection.</p><p><strong>Results: </strong>During a mean follow-up of 27 ± 9 months, 48 of 355 patients (13.8%) underwent revision surgery due to construct failure. Revision-free survival was 86.9% at 1 year, 82.7% at 2 years, and 80.9% at 3 years. In the baseline Cox proportional hazards model, a higher CCI (HR 1.08 per point increase, 95% CI 1.00-1.16; p = 0.048) and elevated CRP (HR 1.004 per mg/L increase, 95% CI 1.001-1.007; p = 0.018) were independently associated with an increased hazard of revision surgery due to construct failure.In the extended model, relapse infection emerged as the strongest predictor of revision surgery due to construct failure (HR 11.54, 95% CI 5.05-26.36; p < 0.001), while CCI and preoperative CRP remained significant. Age, osteoporosis, and wound infection were not independently associated with revision surgery due to construct failure.</p><p><strong>Conclusion: </strong>Greater comorbidity burden and elevated preoperative CRP were associated with an increased risk of revision surgery due to construct failure, whereas postoperative relapse infection was strongly associated to revision surgery. Optimized risk stratification and stringent infection control may help to reduce revision risk.</p>","PeriodicalId":72443,"journal":{"name":"Brain & spine","volume":"6 ","pages":"106283"},"PeriodicalIF":2.7000,"publicationDate":"2026-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13499375/pdf/","citationCount":"0","resultStr":"{\"title\":\"Risk factors for revision surgery due to construct failure after instrumented treatment of pyogenic spondylodiscitis.\",\"authors\":\"Bilal Younes, Dorothee Mielke, Charlotte Flüh, Veit Rohde, Tammam Abboud\",\"doi\":\"10.1016/j.bas.2026.106283\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Construct failure following instrumented treatment for pyogenic spondylodiscitis remains a significant clinical challenge and is often associated with persistent pain or neurological deterioration requiring revision surgery. This study aimed to identify risk factors for construct failure requiring revision surgery after instrumented treatment of pyogenic spondylodiscitis.</p><p><strong>Methods: </strong>This retrospective single-center cohort study included 355 patients who underwent dorsal spinal instrumentation with or without anterior reconstruction for pyogenic spondylodiscitis at the University Medical Center Göttingen between 2013 and 2022. Construct failure requiring revision surgery was defined as the primary endpoint. Time-to-event analyses were performed using Kaplan-Meier survival estimates and Cox proportional hazards regression models. Baseline predictors included age, Charlson Comorbidity Index (CCI), preoperative C-reactive protein (CRP), and osteoporosis. An extended model additionally incorporated postoperative relapse infection and wound infection.</p><p><strong>Results: </strong>During a mean follow-up of 27 ± 9 months, 48 of 355 patients (13.8%) underwent revision surgery due to construct failure. Revision-free survival was 86.9% at 1 year, 82.7% at 2 years, and 80.9% at 3 years. In the baseline Cox proportional hazards model, a higher CCI (HR 1.08 per point increase, 95% CI 1.00-1.16; p = 0.048) and elevated CRP (HR 1.004 per mg/L increase, 95% CI 1.001-1.007; p = 0.018) were independently associated with an increased hazard of revision surgery due to construct failure.In the extended model, relapse infection emerged as the strongest predictor of revision surgery due to construct failure (HR 11.54, 95% CI 5.05-26.36; p < 0.001), while CCI and preoperative CRP remained significant. Age, osteoporosis, and wound infection were not independently associated with revision surgery due to construct failure.</p><p><strong>Conclusion: </strong>Greater comorbidity burden and elevated preoperative CRP were associated with an increased risk of revision surgery due to construct failure, whereas postoperative relapse infection was strongly associated to revision surgery. Optimized risk stratification and stringent infection control may help to reduce revision risk.</p>\",\"PeriodicalId\":72443,\"journal\":{\"name\":\"Brain & spine\",\"volume\":\"6 \",\"pages\":\"106283\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2026-08-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13499375/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Brain & spine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.bas.2026.106283\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2026/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain & spine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.bas.2026.106283","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的:化脓性脊柱炎器械治疗后结构失败仍然是一个重大的临床挑战,通常伴有持续疼痛或神经功能恶化,需要翻修手术。本研究旨在确定化脓性脊柱炎器械治疗后需要翻修手术的构造失败的危险因素。方法:这项回顾性单中心队列研究纳入了355名2013年至2022年间在大学医学中心Göttingen接受了背侧脊柱内固定或不进行前路重建的化脓性脊柱炎患者。结构失败需要翻修手术被定义为主要终点。使用Kaplan-Meier生存估计和Cox比例风险回归模型进行时间-事件分析。基线预测指标包括年龄、Charlson合并症指数(CCI)、术前c反应蛋白(CRP)和骨质疏松症。扩展模型还包括术后复发感染和伤口感染。结果:在平均27 ± 9个月的随访期间,355例患者中有48例(13.8%)因构造失败进行了翻修手术。1年无修正生存率为86.9%,2年为82.7%,3年为80.9%。在基线Cox比例风险模型中,较高的CCI(每增加一个点的风险比为1.08,95% CI为1.00-1.16;p = 0.048)和升高的CRP(每增加一个mg/L的风险比为1.004,95% CI为1.001-1.007;p = 0.018)与由于构建体失败而增加的翻修手术风险独立相关。在扩展模型中,复发感染成为因构建失败而翻修手术的最强预测因子(HR 11.54, 95% CI 5.05-26.36; p )结论:更大的合病负担和术前CRP升高与因构建失败而翻修手术的风险增加相关,而术后复发感染与翻修手术密切相关。优化的风险分层和严格的感染控制有助于降低翻修风险。
Risk factors for revision surgery due to construct failure after instrumented treatment of pyogenic spondylodiscitis.
Objective: Construct failure following instrumented treatment for pyogenic spondylodiscitis remains a significant clinical challenge and is often associated with persistent pain or neurological deterioration requiring revision surgery. This study aimed to identify risk factors for construct failure requiring revision surgery after instrumented treatment of pyogenic spondylodiscitis.
Methods: This retrospective single-center cohort study included 355 patients who underwent dorsal spinal instrumentation with or without anterior reconstruction for pyogenic spondylodiscitis at the University Medical Center Göttingen between 2013 and 2022. Construct failure requiring revision surgery was defined as the primary endpoint. Time-to-event analyses were performed using Kaplan-Meier survival estimates and Cox proportional hazards regression models. Baseline predictors included age, Charlson Comorbidity Index (CCI), preoperative C-reactive protein (CRP), and osteoporosis. An extended model additionally incorporated postoperative relapse infection and wound infection.
Results: During a mean follow-up of 27 ± 9 months, 48 of 355 patients (13.8%) underwent revision surgery due to construct failure. Revision-free survival was 86.9% at 1 year, 82.7% at 2 years, and 80.9% at 3 years. In the baseline Cox proportional hazards model, a higher CCI (HR 1.08 per point increase, 95% CI 1.00-1.16; p = 0.048) and elevated CRP (HR 1.004 per mg/L increase, 95% CI 1.001-1.007; p = 0.018) were independently associated with an increased hazard of revision surgery due to construct failure.In the extended model, relapse infection emerged as the strongest predictor of revision surgery due to construct failure (HR 11.54, 95% CI 5.05-26.36; p < 0.001), while CCI and preoperative CRP remained significant. Age, osteoporosis, and wound infection were not independently associated with revision surgery due to construct failure.
Conclusion: Greater comorbidity burden and elevated preoperative CRP were associated with an increased risk of revision surgery due to construct failure, whereas postoperative relapse infection was strongly associated to revision surgery. Optimized risk stratification and stringent infection control may help to reduce revision risk.